Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Locke

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Epilepsy & Behavior : E&B|February 14, 2006
Every-12-hour administration of extended-release divalproex in patients with epilepsy: impact on plasma valproic acid concentrationsRonald C Reed, Sandeep Dutta, John H Cavanaugh, et al.
International Journal of Biological Macromolecules|August 29, 2015
Poly(3-hydroxybutyrate)-ethyl cellulose based bio-composites with novel characteristics for infection free wound healing applicationHafiz M N Iqbal, Godfrey Kyazze, Ian Charles Locke, et al.
Pain|June 3, 2015
Effects of a T-type calcium channel blocker, ABT-639, on spontaneous activity in C-nociceptors in patients with painful diabetic neuropathy: a randomized controlled trialJordi Serra, W Rachel Duan, Charles Locke, et al.
British Journal of Clinical Pharmacology|September 29, 2012
Safety, tolerability and pharmacokinetics of the histamine H3 receptor antagonist, ABT-288, in healthy young adults and elderly volunteersAhmed A Othman, George Haig, Hana Florian, et al.
Clinical Pharmacology in Drug Development|January 9, 2024
Comparability of Elezanumab Safety, Tolerability, and Pharmacokinetics in Healthy Japanese, Chinese, and White ParticipantsHari V Kalluri, Matthew R Rosebraugh, Nils Boehm, et al.
Journal of Hospital Medicine|January 6, 2015
Changes to inpatient versus outpatient hospitalization: Medicare's 2-midnight ruleCharles Locke, Ann M Sheehy, Amy Deutschendorf, et al.
Thyroid : Official Journal of the American Thyroid Association|April 10, 2004
Are bioequivalence studies of levothyroxine sodium formulations in euthyroid volunteers reliable?Vicky Blakesley, Walid Awni, Charles Locke, et al.
Journal of Biopharmaceutical Statistics|May 13, 2008
QT/QTc prolongation in placebo-treated subjects: a PhRMA collaborative data analysisMarilyn A Agin, William S Aronstein, Georg Ferber, et al.
The AAPS Journal|December 12, 2012
Pharmacokinetics of levodopa, carbidopa, and 3-O-methyldopa following 16-hour jejunal infusion of levodopa-carbidopa intestinal gel in advanced Parkinson's disease patientsDag Nyholm, Per Odin, Anders Johansson, et al.
Pharmacology Research & Perspectives|April 13, 2019
Levodopa-carbidopa intestinal gel high concentration formulation is clinically bioequivalent to commercial formulationMatthew Rosebraugh, Hari V Kalluri, Wei Liu, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Epilepsy & Behavior : E&B|February 14, 2006
Every-12-hour administration of extended-release divalproex in patients with epilepsy: impact on plasma valproic acid concentrationsRonald C Reed, Sandeep Dutta, John H Cavanaugh, et al.
International Journal of Biological Macromolecules|August 29, 2015
Poly(3-hydroxybutyrate)-ethyl cellulose based bio-composites with novel characteristics for infection free wound healing applicationHafiz M N Iqbal, Godfrey Kyazze, Ian Charles Locke, et al.
Pain|June 3, 2015
Effects of a T-type calcium channel blocker, ABT-639, on spontaneous activity in C-nociceptors in patients with painful diabetic neuropathy: a randomized controlled trialJordi Serra, W Rachel Duan, Charles Locke, et al.
British Journal of Clinical Pharmacology|September 29, 2012
Safety, tolerability and pharmacokinetics of the histamine H3 receptor antagonist, ABT-288, in healthy young adults and elderly volunteersAhmed A Othman, George Haig, Hana Florian, et al.
Clinical Pharmacology in Drug Development|January 9, 2024
Comparability of Elezanumab Safety, Tolerability, and Pharmacokinetics in Healthy Japanese, Chinese, and White ParticipantsHari V Kalluri, Matthew R Rosebraugh, Nils Boehm, et al.
Journal of Hospital Medicine|January 6, 2015
Changes to inpatient versus outpatient hospitalization: Medicare's 2-midnight ruleCharles Locke, Ann M Sheehy, Amy Deutschendorf, et al.
Thyroid : Official Journal of the American Thyroid Association|April 10, 2004
Are bioequivalence studies of levothyroxine sodium formulations in euthyroid volunteers reliable?Vicky Blakesley, Walid Awni, Charles Locke, et al.
Journal of Biopharmaceutical Statistics|May 13, 2008
QT/QTc prolongation in placebo-treated subjects: a PhRMA collaborative data analysisMarilyn A Agin, William S Aronstein, Georg Ferber, et al.
The AAPS Journal|December 12, 2012
Pharmacokinetics of levodopa, carbidopa, and 3-O-methyldopa following 16-hour jejunal infusion of levodopa-carbidopa intestinal gel in advanced Parkinson's disease patientsDag Nyholm, Per Odin, Anders Johansson, et al.
Pharmacology Research & Perspectives|April 13, 2019
Levodopa-carbidopa intestinal gel high concentration formulation is clinically bioequivalent to commercial formulationMatthew Rosebraugh, Hari V Kalluri, Wei Liu, et al.
Pageof 3